Anggaya, Nethan .
HRN: 20-12-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
04/25/2023
05/02/2023
IV
2.5ml
Bid
Acute Tonsilo Pharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes